Skip to content

Clinical trials

Phase 1/2 Melanoma trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Melanoma Phase: Phase 1/2 Country / region: Netherlands Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20091
20101
20111
20121
20132
20153
20162
20181
20191
20202
20222
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting5
Terminated3
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Radboud University Medical Center5
The Netherlands Cancer Institute5
Novartis Pharmaceuticals3
Array BioPharma1
Array Biopharma, now a wholly owned subsidiary of Pfizer1
BBB-Therapeutics B.V.1
Daiichi Sankyo1
Erasmus Medical Center1
Genmab1
Leiden University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Melanoma21
Uveal Melanoma4
Carcinoma, Non-Small-Cell Lung3
Endometrial Neoplasms2
Neoplasms2
Ovarian Neoplasms2
Uterine Cervical Neoplasms2
Biliary Tract Neoplasms1
Brain Diseases1
Brain Neoplasms1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.